<p><h1>Global Pertussis Vaccination Market by Types, Applications, and Major Players, with Regional Growth Rate Analysis and Development Situation, from 2025 to 2032</h1></p><p><strong>Pertussis Vaccination Market Analysis and Latest Trends</strong></p>
<p><p>Pertussis vaccination is a critical immunization aimed at protecting against whooping cough, a highly contagious respiratory disease caused by the Bordetella pertussis bacteria. Vaccination is commonly included in combination vaccines like DTaP, which protects against diphtheria, tetanus, and pertussis. The rising incidence of pertussis outbreaks, particularly in adolescents and adults, has increased awareness and demand for vaccination.</p><p>The Pertussis Vaccination Market is expected to grow at a CAGR of 14% during the forecast period. This growth is driven by several factors, including increasing healthcare expenditure, government initiatives to promote immunization, and the rising prevalence of pertussis in various age groups. Additionally, advancements in vaccine technology and an expanding portfolio of combination vaccines are contributing to market expansion.</p><p>Recent trends indicate a growing emphasis on booster doses for adults and pregnant women to enhance community immunity. Furthermore, educational campaigns to raise awareness about the importance of vaccination, along with improved accessibility through healthcare systems, are expected to bolster market growth. Overall, the focus on preventing infectious diseases is anticipated to sustain the momentum of the pertussis vaccination market in the coming years.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliablebusinessarena.com/enquiry/request-sample/1871017?utm_campaign=3213&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=19042025&utm_id=pertussis-vaccination">https://www.reliablebusinessarena.com/enquiry/request-sample/1871017</a></p>
<p>&nbsp;</p>
<p><strong>Pertussis Vaccination Major Market Players</strong></p>
<p><p>The pertussis vaccination market has several key players leveraging their expertise in biologics and vaccine development. Among them, Sanofi Pasteur and GSK stand out as market leaders with established portfolios and global reach. Sanofi Pasteur offers its Boostrix and Adacel vaccines, targeting both pediatric and adolescent populations. GSK, with itsInfanrix and Boostrix products, is also a significant player, focusing on combination vaccines to boost immunity levels efficiently.</p><p>Mitsubishi Tanabe Pharma and KM Biologics, both based in Japan, have been expanding their foothold in the Asian market, with a particular focus on innovative formulations and delivery methods to enhance vaccine uptake. In China, companies like Wuhan Institute of Biological Products and Walvax Biotechnology play critical roles in local distribution and manufacturing. Chengdu Institute of Biological Products and Minhai Biotechnology add to the competition by contributing to domestic production and innovative research in vaccine safety and efficacy.</p><p>The overall pertussis vaccination market is expected to grow due to increasing awareness of vaccine-preventable diseases, government initiatives, and rising incidence rates of pertussis. Sanofi Pasteur reported sales revenue of approximately $10 billion in the vaccine segment, while GSK indicated around $6 billion from their vaccine portfolio, which includes pertussis products. </p><p>Future growth for these players will depend on advancements in vaccine formulations, potential new market entry, and partnerships with healthcare providers to enhance immunization rates. With global vaccination initiatives gaining traction, particularly in developing regions, the pertussis vaccination market is poised for substantial growth in the coming years, driven by both emerging players and established industry leaders.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For Pertussis Vaccination Manufacturers?</strong></p>
<p><p>The pertussis vaccination market is poised for growth, driven by rising awareness of vaccine-preventable diseases and increasing global vaccination recommendations. In 2022, the market was valued at approximately $1.2 billion, with a projected CAGR of 5.5% through 2030. Several countries are enhancing immunization programs, particularly targeting adolescents and pregnant women. Innovations in vaccine formulation and delivery methods, coupled with government initiatives, are expected to boost penetration. Additionally, the ongoing emphasis on herd immunity will further fuel demand, positioning the pertussis vaccination market as a critical component of global health strategies in the coming years.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliablebusinessarena.com/enquiry/pre-order-enquiry/1871017?utm_campaign=3213&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=19042025&utm_id=pertussis-vaccination">https://www.reliablebusinessarena.com/enquiry/pre-order-enquiry/1871017</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The Pertussis Vaccination Market Analysis by types is segmented into:</strong></p>
<p><ul><li>Acellular Vaccines</li><li>Whole-cell Vaccines</li></ul></p>
<p><p>The pertussis vaccination market is primarily categorized into acellular vaccines and whole-cell vaccines. Acellular vaccines, comprising purified components of the Bordetella pertussis bacteria, offer fewer side effects and are preferred for their safety and efficacy. Conversely, whole-cell vaccines contain the entire inactivated bacteria, providing robust immune responses but often associated with more severe side effects. The choice of vaccine type influences public health strategies, vaccination programs, and overall community protection against pertussis outbreaks.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliablebusinessarena.com/purchase/1871017?utm_campaign=3213&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=19042025&utm_id=pertussis-vaccination">https://www.reliablebusinessarena.com/purchase/1871017</a></p>
<p>&nbsp;</p>
<p><strong>The Pertussis Vaccination Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>12 Months Below</li><li>12 Months Above</li></ul></p>
<p><p>The Pertussis Vaccination Market for infants under 12 months and those above 12 months is critical for public health. Vaccination under 12 months focuses on preventing severe whooping cough in vulnerable infants, adhering to recommended immunization schedules. For those above 12 months, booster shots are essential to maintain immunity as initial vaccinations wane. Both segments emphasize a comprehensive strategy to reduce outbreak risks, ensuring herd immunity and safeguarding community health through timely vaccination interventions.</p></p>
<p><a href="https://www.reliablebusinessarena.com/pertussis-vaccination-r1871017?utm_campaign=3213&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=19042025&utm_id=pertussis-vaccination">&nbsp;https://www.reliablebusinessarena.com/pertussis-vaccination-r1871017</a></p>
<p><strong>In terms of Region, the Pertussis Vaccination Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The pertussis vaccination market is witnessing significant growth across various regions. North America and Europe are expected to dominate, collectively accounting for approximately 60% of the market share, driven by robust vaccination programs and public health initiatives. Asia-Pacific (APAC) is emerging rapidly, projected to capture around 25% share due to increasing awareness and government support. Meanwhile, China is anticipated to hold about 15% share, fueled by rising healthcare investments and vaccination coverage improvements, enhancing overall market dynamics.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliablebusinessarena.com/purchase/1871017?utm_campaign=3213&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=19042025&utm_id=pertussis-vaccination">https://www.reliablebusinessarena.com/purchase/1871017</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliablebusinessarena.com/enquiry/request-sample/1871017?utm_campaign=3213&utm_medium=2&utm_source=Github&utm_content=ia&utm_term=19042025&utm_id=pertussis-vaccination">https://www.reliablebusinessarena.com/enquiry/request-sample/1871017</a></p>
<p><strong></strong></p>
<p><p></p><p></p><p></p></p>